Hipoglisemi

Lauri C, Tamminga M, Glaudemans A, et al. Detection of Osteomyelitis in the Diabetic Foot by Imaging Techniques: A Systematic Review and Meta-analysis Comparing MRI, White Blood Cell Scintigraphy, and FDG-PET. Diabetes Care. 2017;40(8):1111-20.

Rehni AK, Dave KR. Impact of Hypoglycemia on Brain Metabolism During Diabetes. Mol Neurobiol. 2018;55(12):9075-88.

Koca N, Cander S, Gul OO, et al. Insulinoma Case Admitted with Reactive Hypoglycemia Symptoms. Curr Diabetes Rev. 2020;16(7):790-6.

Alsahli M, Gerich JE. Hypoglycemia. Endocrinol Metab Clin North Am. 2013;42(4):657-76.

Anderson JW, Herman RH. Classification of reactive hypoglycemia. Am J Clin Nutr. 1969;22(5):646-50.

Hall M, Walicka M, Traczyk I. [Reactive hypoglycemia - an interdisciplinary approach of the disease of XXI Century]. Wiad Lek. 2020;73(2):384-9.

Taniyama M, Iida S. [Idiopathic reactive hypoglycemia]. Nihon Rinsho. 2006;Suppl 3:230-2.

Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007;87(4):1409-39.

Galati SJ, Rayfield EJ. Approach to the patient with postprandial hypoglycemia. Endocr Pract. 2014;20(4):331-40.

Freeland B. Hypoglycemia in Diabetes Mellitus. Home Healthc Now. 2017;35(8):414-9.

Silbert R, Salcido-Montenegro A, Rodriguez-Gutierrez R, et al. Hypoglycemia Among Patients with Type 2 Diabetes: Epidemiology, Risk Factors, and Prevention Strategies. Curr Diab Rep. 2018;18(8):53.

Brun JF, Fedou C, Mercier J. Postprandial reactive hypoglycemia. Diabetes Metab. 2000;26(5):337-51.

Hofeldt FD. Reactive hypoglycemia. Endocrinol Metab Clin North Am. 1989;18(1):185-201.

Iihara M, Obara T. Minimally invasive endocrine surgery: laparoscopic resection of insulinomas. Biomed Pharmacother. 2002;56 Suppl 1:227s-30s.

Lo CY, Lo CM, Fan ST. Role of laparoscopic ultrasonography in intraoperative localization of pancreatic insulinoma. Surg Endosc. 2000;14(12):1131-5.

Norton JA, Shawker TH, Doppman JL, et al. Localization and surgical treatment of occult insulinomas. Ann Surg. 1990;212(5):615-20.

Hirshberg B, Libutti SK, Alexander HR, et al. Blind distal pancreatectomy for occult insulinoma, an inadvisable procedure. J Am Coll Surg. 2002;194(6):761-4.

Gouta EL, Jerraya H, Dougaz W, et al. Endogenous hyperinsulinism: diagnostic and therapeutic difficulties. Pan Afr Med J. 2019;33:57.

de Santibañes M, Cristiano A, Mazza O, et al. Endogenous hyperinsulinemic hypoglycemia syndrome: surgical treatment. Cir Esp. 2014;92(8):547-52.

Monami M, Aleffi S. Hyperglycemia, hypoglycemia and glycemic variability in the elderly: a fatal triad? Monaldi Arch Chest Dis. 2016;84(1-2):726.

Giurini JM, Cook EA, Cook JJ. Diabetes: the latest trends in glycemic control. Clin Podiatr Med Surg. 2007;24(2):159-89.

Golightly LK, Jones MA, Hamamura DH, et al. Management of diabetes mellitus in hospitalized patients: efficiency and effectiveness of sliding-scale insulin therapy. Pharmacotherapy. 2006;26(10):1421-32.

Moghissi ES, Hirsch IB. Hospital management of diabetes. Endocrinol Metab Clin North Am. 2005;34(1):99-116.

Rzepczyk S, Dolińska-Kaczmarek K, Uruska A, et al.The Other Face of Insulin-Overdose and Its Effects. Toxics. 2022;10(3).

Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care. 2003;26(6):1902-12.

Yamada T, Shojima N, Noma H, et al. Glycemic control, mortality, and hypoglycemia in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials. Intensive Care Med. 2017;43(1):1-15.

Glatstein M, Scolnik D, Bentur Y. Octreotide for the treatment of sulfonylurea poisoning. Clin Toxicol (Phila). 2012;50(9):795-804.

Ford W, Self WH, Slovis C, et al. Diabetes in the Emergency Department and Hospital: Acute Care of Diabetes Patients. Curr Emerg Hosp Med Rep. 2013;1(1):1-9.

Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013;36(5):1384-95.

Cryer PE, Axelrod L, Grossman AB, et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2009;94(3):709-28.

Kandaswamy L, Raghavan R, Pappachan JM. Spontaneous hypoglycemia: diagnostic evaluation and management. Endocrine. 2016;53(1):47-57.

Kittah NE, Vella A. Management Of Endocrine Disease: Pathogenesis and management of hypoglycemia. Eur J Endocrinol. 2017;177(1):R37-r47.

Martens P, Tits J. Approach to the patient with spontaneous hypoglycemia. Eur J Intern Med. 2014;25(5):415-21.

Qaseem A, Barry MJ, Humphrey LL, et al. Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians. Ann Intern Med. 2017;166(4):279-90.

Htike ZZ, Zaccardi F, Papamargaritis D, et al. Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes: A systematic review and mixed-treatment comparison analysis. Diabetes Obes Metab. 2017;19(4):524-36.

Association AD. 2. Classification and Diagnosis of Diabetes. Diabetes Care. 2017;40(Suppl 1):S11-s24.

Madsbad S. Review of head-to-head comparisons of glucagon-like peptide-1 receptor agonists. Diabetes Obes Metab. 2016;18(4):317-32.

Raz I. Guideline approach to therapy in patients with newly diagnosed type 2 diabetes. Diabetes Care. 2013;36 Suppl 2(Suppl 2):S139-44.

Maruthur NM, Tseng E, Hutfless S, et al. Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis. Ann Intern Med. 2016;164(11):740-51.

Umpierrez GE, Hellman R, Korytkowski MT, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(1):16-38.

Garber AJ, Abrahamson MJ, Barzilay JI, et al. Consensus Statement By The American Association Of Clinical Endocrinologists And American College Of Endocrinology On The Comprehensive Type 2 Diabetes Management Algorithm - 2017 Executive Summary. Endocr Pract. 2017;23(2):207-38.

Demaerschalk BM, Kleindorfer DO, Adeoye OM, et al. Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2016;47(2):581-641.

Mahaffey KW, Granger CB, Toth CA, et al. Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries. J Am Coll Cardiol. 1997;30(7):1606-10.

Dhawan B, Soni R, Singh R, et al. Endocapsular hematoma: a rare form of ocular hemorrhage after thrombolysis with streptokinase. N Am J Med Sci. 2014;6(8):425-7.

Mandell JC, Khurana B, Smith JT, et al. Osteomyelitis of the lower extremity: pathophysiology, imaging, and classification, with an emphasis on diabetic foot infection. Emerg Radiol. 2018;25(2):175-88.

Markakis K, Bowling FL, Boulton AJ. The diabetic foot in 2015: an overview. Diabetes Metab Res Rev. 2016;32 Suppl 1:169-78.

Lipsky BA, Aragón-Sánchez J, Diggle M,et al. IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes. Diabetes Metab Res Rev. 2016;32 Suppl 1:45-74.

Lipsky BA, Berendt AR, Cornia PB, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54(12):e132-73.

Hodgson K, Morris J, Bridson T, et al. Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections. Immunology. 2015;144(2):171-85.

Karaca Ü, Schram MT, Houben AJ, et al. Microvascular dysfunction as a link between obesity, insulin resistance and hypertension. Diabetes Res Clin Pract. 2014;103(3):382-7.

Bagger JI, Knop FK, Lund A, et al. Impaired regulation of the incretin effect in patients with type 2 diabetes. J Clin Endocrinol Metab. 2011;96(3):737-45.

Forst T, Heise T, Plum-Morschel L. Pharmacological Intervention in Type 2 Diabetes Mellitus - A Pathophysiologically Reasoned Approach? Curr Diabetes Rev. 2016;12(4):429-39.

Leese GP, Wang J, Broomhall J, et al. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care. 2003;26(4):1176-80.

Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet. 2011;378(9785):31-40.

Lauri C, Tamminga M, Glaudemans A, et al. Detection of Osteomyelitis in the Diabetic Foot by Imaging Techniques: A Systematic Review and Meta-analysis Comparing MRI, White Blood Cell Scintigraphy, and FDG-PET. Diabetes Care. 2017;40(8):1111-20.

Rehni AK, Dave KR. Impact of Hypoglycemia on Brain Metabolism During Diabetes. Mol Neurobiol. 2018;55(12):9075-88.

Koca N, Cander S, Gul OO, et al. Insulinoma Case Admitted with Reactive Hypoglycemia Symptoms. Curr Diabetes Rev. 2020;16(7):790-6.

Alsahli M, Gerich JE. Hypoglycemia. Endocrinol Metab Clin North Am. 2013;42(4):657-76.

Anderson JW, Herman RH. Classification of reactive hypoglycemia. Am J Clin Nutr. 1969;22(5):646-50.

Hall M, Walicka M, Traczyk I. [Reactive hypoglycemia - an interdisciplinary approach of the disease of XXI Century]. Wiad Lek. 2020;73(2):384-9.

Taniyama M, Iida S. [Idiopathic reactive hypoglycemia]. Nihon Rinsho. 2006;Suppl 3:230-2.

Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007;87(4):1409-39.

Galati SJ, Rayfield EJ. Approach to the patient with postprandial hypoglycemia. Endocr Pract. 2014;20(4):331-40.

Freeland B. Hypoglycemia in Diabetes Mellitus. Home Healthc Now. 2017;35(8):414-9.

Silbert R, Salcido-Montenegro A, Rodriguez-Gutierrez R, et al. Hypoglycemia Among Patients with Type 2 Diabetes: Epidemiology, Risk Factors, and Prevention Strategies. Curr Diab Rep. 2018;18(8):53.

Brun JF, Fedou C, Mercier J. Postprandial reactive hypoglycemia. Diabetes Metab. 2000;26(5):337-51.

Hofeldt FD. Reactive hypoglycemia. Endocrinol Metab Clin North Am. 1989;18(1):185-201.

Iihara M, Obara T. Minimally invasive endocrine surgery: laparoscopic resection of insulinomas. Biomed Pharmacother. 2002;56 Suppl 1:227s-30s.

Lo CY, Lo CM, Fan ST. Role of laparoscopic ultrasonography in intraoperative localization of pancreatic insulinoma. Surg Endosc. 2000;14(12):1131-5.

Norton JA, Shawker TH, Doppman JL, et al. Localization and surgical treatment of occult insulinomas. Ann Surg. 1990;212(5):615-20.

Hirshberg B, Libutti SK, Alexander HR, et al. Blind distal pancreatectomy for occult insulinoma, an inadvisable procedure. J Am Coll Surg. 2002;194(6):761-4.

Gouta EL, Jerraya H, Dougaz W, et al. Endogenous hyperinsulinism: diagnostic and therapeutic difficulties. Pan Afr Med J. 2019;33:57.

de Santibañes M, Cristiano A, Mazza O, et al. Endogenous hyperinsulinemic hypoglycemia syndrome: surgical treatment. Cir Esp. 2014;92(8):547-52.

Monami M, Aleffi S. Hyperglycemia, hypoglycemia and glycemic variability in the elderly: a fatal triad? Monaldi Arch Chest Dis. 2016;84(1-2):726.

Giurini JM, Cook EA, Cook JJ. Diabetes: the latest trends in glycemic control. Clin Podiatr Med Surg. 2007;24(2):159-89.

Golightly LK, Jones MA, Hamamura DH, et al. Management of diabetes mellitus in hospitalized patients: efficiency and effectiveness of sliding-scale insulin therapy. Pharmacotherapy. 2006;26(10):1421-32.

Moghissi ES, Hirsch IB. Hospital management of diabetes. Endocrinol Metab Clin North Am. 2005;34(1):99-116.

Rzepczyk S, Dolińska-Kaczmarek K, Uruska A, et al.The Other Face of Insulin-Overdose and Its Effects. Toxics. 2022;10(3).

Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care. 2003;26(6):1902-12.

Yamada T, Shojima N, Noma H, et al. Glycemic control, mortality, and hypoglycemia in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials. Intensive Care Med. 2017;43(1):1-15.

Glatstein M, Scolnik D, Bentur Y. Octreotide for the treatment of sulfonylurea poisoning. Clin Toxicol (Phila). 2012;50(9):795-804.

Ford W, Self WH, Slovis C, et al. Diabetes in the Emergency Department and Hospital: Acute Care of Diabetes Patients. Curr Emerg Hosp Med Rep. 2013;1(1):1-9.

Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013;36(5):1384-95.

Cryer PE, Axelrod L, Grossman AB, et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2009;94(3):709-28.

Kandaswamy L, Raghavan R, Pappachan JM. Spontaneous hypoglycemia: diagnostic evaluation and management. Endocrine. 2016;53(1):47-57.

Kittah NE, Vella A. Management Of Endocrine Disease: Pathogenesis and management of hypoglycemia. Eur J Endocrinol. 2017;177(1):R37-r47.

Martens P, Tits J. Approach to the patient with spontaneous hypoglycemia. Eur J Intern Med. 2014;25(5):415-21.

Qaseem A, Barry MJ, Humphrey LL, et al. Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians. Ann Intern Med. 2017;166(4):279-90.

Htike ZZ, Zaccardi F, Papamargaritis D, et al. Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes: A systematic review and mixed-treatment comparison analysis. Diabetes Obes Metab. 2017;19(4):524-36.

Association AD. 2. Classification and Diagnosis of Diabetes. Diabetes Care. 2017;40(Suppl 1):S11-s24.

Madsbad S. Review of head-to-head comparisons of glucagon-like peptide-1 receptor agonists. Diabetes Obes Metab. 2016;18(4):317-32.

Raz I. Guideline approach to therapy in patients with newly diagnosed type 2 diabetes. Diabetes Care. 2013;36 Suppl 2(Suppl 2):S139-44.

Maruthur NM, Tseng E, Hutfless S, et al. Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis. Ann Intern Med. 2016;164(11):740-51.

Umpierrez GE, Hellman R, Korytkowski MT, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(1):16-38.

Garber AJ, Abrahamson MJ, Barzilay JI, et al. Consensus Statement By The American Association Of Clinical Endocrinologists And American College Of Endocrinology On The Comprehensive Type 2 Diabetes Management Algorithm - 2017 Executive Summary. Endocr Pract. 2017;23(2):207-38.

Demaerschalk BM, Kleindorfer DO, Adeoye OM, et al. Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2016;47(2):581-641.

Mahaffey KW, Granger CB, Toth CA, et al. Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries. J Am Coll Cardiol. 1997;30(7):1606-10.

Dhawan B, Soni R, Singh R, et al. Endocapsular hematoma: a rare form of ocular hemorrhage after thrombolysis with streptokinase. N Am J Med Sci. 2014;6(8):425-7.

Mandell JC, Khurana B, Smith JT, et al. Osteomyelitis of the lower extremity: pathophysiology, imaging, and classification, with an emphasis on diabetic foot infection. Emerg Radiol. 2018;25(2):175-88.

Markakis K, Bowling FL, Boulton AJ. The diabetic foot in 2015: an overview. Diabetes Metab Res Rev. 2016;32 Suppl 1:169-78.

Lipsky BA, Aragón-Sánchez J, Diggle M,et al. IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes. Diabetes Metab Res Rev. 2016;32 Suppl 1:45-74.

Lipsky BA, Berendt AR, Cornia PB, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54(12):e132-73.

Hodgson K, Morris J, Bridson T, et al. Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections. Immunology. 2015;144(2):171-85.

Karaca Ü, Schram MT, Houben AJ, et al. Microvascular dysfunction as a link between obesity, insulin resistance and hypertension. Diabetes Res Clin Pract. 2014;103(3):382-7.

Bagger JI, Knop FK, Lund A, et al. Impaired regulation of the incretin effect in patients with type 2 diabetes. J Clin Endocrinol Metab. 2011;96(3):737-45.

Forst T, Heise T, Plum-Morschel L. Pharmacological Intervention in Type 2 Diabetes Mellitus - A Pathophysiologically Reasoned Approach? Curr Diabetes Rev. 2016;12(4):429-39.

Leese GP, Wang J, Broomhall J, et al. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care. 2003;26(4):1176-80.

Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet. 2011;378(9785):31-40.